Browse by author
Lookup NU author(s): Professor Yen Nee Tan
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
A PEGylated niosomal formulation of cyclophosphamide (Nio-Cyclo-PEG) was prepared using a central composite design and characterized in terms of drug loading, size distribution, and average size. The stability of formulations was also studied at different conditions. In vitro cytotoxicity of drug delivery formulations was assessed on gastric cancer cells using MTT assay. The mechanism of cytotoxicity was studied at the transcriptional level by real-time PCR on Caspase3, Caspase9, CyclinD, CyclinE, MMP-2, and MMP-9 genes, while apoptosis was investigated with flow cytometry. The anti-metastatic property was evaluated using the scratch method. Propidium iodide staining was used to study the cell cycle. The results indicated that the as-designed nanocarrier exhibited a controlled drug release pattern with improved nanoparticle stability. It was found that the living cancer cells treated with Nio-Cyclo-PEG showed a significant decrease in number when compared with the niosomal carrier without PEG (Nio-Cyclo) and free drug (Cyclo). Moreover, the drug-loaded nanocarrier induced planned death (apoptosis) in the cancer cells through the regulation of Caspase3, Caspase9, CyclinD, CyclinE, MMP-9, and MMP-2 gene expression, indicating that the Nio-Cyclo-PEG formulation could significantly inhibit the cell cycle at the sub G1 phase as well as prevent the migration of cancer cells. In conclusion, Nio-Cyclo-PEG as developed in this study could serve as an active-targeting drug delivery nanocarriers for gastric cancer therapy with high efficacy and minimal side effects on healthy tissues/cells.
Author(s): Khodabakhsh F, Bourbour M, Yaraki MT, Bazzazan S, Bakhshandeh H, Ahangari Cohan R, Tan YN
Publication type: Article
Publication status: Published
Journal: Molecules
Year: 2022
Volume: 27
Issue: 17
Online publication date: 24/08/2022
Acceptance date: 18/08/2022
Date deposited: 20/09/2022
ISSN (electronic): 1420-3049
Publisher: MDPI
URL: https://doi.org/10.3390/molecules27175418
DOI: 10.3390/molecules27175418
PubMed id: 36080186
Altmetrics provided by Altmetric